samedan logo
 
 
spacer
home > subscribe to ICT
ICT SUBSCRIPTION FORM

International Clinical Trials is available free on a controlled basis to strategic decision makers within pharmaceutical companies and their contract partners.

Title:
First Name:
Last Name:
Company Name:
Address 1:
Address 2:
Town / City: ZIP / Post Code:
Country: Other:
Tel.: E-mail:

Please answer the following questions:

1. What is your Primary Field of Work/Business/Industry?



Other:

2. What is your Job Title?



Other:
Additional Information:
Please repeat the security code (not case sensitive)*
   
spacer
News and Press Releases

Oxford Genetics licenses SnapFast™ expression vectors to Twist Bioscience

November 16, 2017, Oxford, England and San Francisco, US. – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced today a new licensing agreement with Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNA. Oxford Genetics will supply Twist Bioscience with its SnapFast™ technology platform to provide a broad range of application-specific expression vectors which Twist Bioscience will use to clone synthesized DNA for its diverse customer base.
More info >>

 
Industry Events

Drug Delivery Partnerships 2018

22-24 January 2018, PGA National Resort & Spa, Palm Beach Gardens, Florida

For 22 years, DDP has been the world’s largest drug delivery meeting place to accelerate drugs to market and lengthen lifecycles for long term profitability by finding new partners, new drug delivery technologies, and new formulation development strategies.
More info >>

.
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement